Regulation of the S100B gene by alpha 1-adrenergic stimulation in cardiac myocytes.

Am J Physiol Heart Circ Physiol

Division of Cardiology, Department of Medicine, The Toronto General Hospital Research Institute, University of Toronto, Ontario M5G 1L6, Canada.

Published: January 2003

We previously reported that S100B, a 20-kDa Ca(2+)-binding homodimer, inhibited the postinfarct myocardial hypertrophic response mediated by alpha(1)-adrenergic stimulation through the protein kinase C (PKC) signaling pathway. In the present study, we examined whether the same pathway induced the S100B gene, supporting the hypothesis that S100B is a feedback negative regulator of this pathway. We transfected cultured neonatal rat cardiac myocytes with a luciferase reporter gene driven by the maximal human S100B promoter and progressively shorter segments of this promoter sequentially deleted from the 5' end. We identified a basic promoter essential for transcription spanning 162 bp upstream of the transcription initiation site and positive (at -782/-162 and -6,689/-4,463) and negative (at -4,463/-782) myocyte-selective regulatory elements. We showed that the basic and maximal S100B promoters were activated specifically by alpha(1)-adrenergic agonists through the alpha(1A)-adrenergic receptor, but not by any other trophic hormonal stimuli. The activation of the S100B promoter was mediated through the PKC signaling pathway. Transcription enhancer factor-1 (TEF-1) and related to TEF-1 (RTEF-1) influenced transcription from the maximal, but not the basic, promoter implicating active MCAT elements upstream from the basic promoter. Acting in opposing fashions, TEF-1 transrepressed the S100B promoter and RTEF-1 transactivated the promoter. Our results suggest that alpha(1)-adrenergic stimulation induces the S100B gene after myocardial infarction through the PKC signaling pathway and that this induction is modulated by TEF-1 and RTEF-1.

Download full-text PDF

Source
http://dx.doi.org/10.1152/ajpheart.00161.2002DOI Listing

Publication Analysis

Top Keywords

s100b gene
12
pkc signaling
12
signaling pathway
12
s100b promoter
12
basic promoter
12
cardiac myocytes
8
s100b
8
alpha1-adrenergic stimulation
8
promoter
8
tef-1 rtef-1
8

Similar Publications

Accumulating the key proteomic signatures associated with delirium: Evidence from systematic review.

PLoS One

December 2024

NHMRC Clinical Trials Centre, Faculty of Medicine and Health, The University of Sydney, Camperdown, New South Wales, Australia.

Article Synopsis
  • Delirium is a serious neuropsychiatric condition seen often in intensive care and post-surgery, leading to longer hospital stays and higher mortality/morbidity rates.
  • A systematic review analyzed 1746 studies on delirium biomarkers from 2000-2023, resulting in the inclusion of 78 studies emphasizing proteomic signatures related to the condition.
  • The review identified 313 proteins, with a focus on 13 key proteins (like IL-6, CRP, and TNF-a) that show a significant link to delirium, highlighting the need for more research to better understand these biomarkers for diagnosis and treatment.
View Article and Find Full Text PDF

Background: Primary central nervous system lymphoma (PCNSL) is a rare lymphoid malignancy. Systemic profiling of the PCNSL tumor microenvironment (TME) was previously conducted through gene expression analysis. We investigated the prognostic impact of TME on survival to establish novel prognostic biomarkers in PCNSL patients.

View Article and Find Full Text PDF

Propofol and midazolam are the current standard of care for prolonged sedation in Intensive Care Units (ICUs). However, the effects and mechanism of these sedatives in brain tissue are unclear. Herein, the development of an ICU patient-on-a-chip platform to elucidate those effects is reported.

View Article and Find Full Text PDF

Breast cancer has emerged as the primary cause of mortality stemming from malignancies among women. HuaChanSu has demonstrated efficacy in suppressing the progression of various malignancies. However, the specific immune targets and pathways influenced by HuaChanSu within mammary tumors remain elusive.

View Article and Find Full Text PDF

Identification of Potential Biomarkers and Therapeutic Targets for Periodontitis.

Int Dent J

November 2024

Department of Periodontics and Oral Mucosal Diseases, The Affiliated Stomatology Hospital, Southwest Medical University, Luzhou, Sichuan, China; School of Stomatology, Southwest Medical University, Luzhou, Sichuan, China; Luzhou Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, The Affiliated Stomatology Hospital, Southwest Medical University, Luzhou, Sichuan, China; Institute of Stomatology, Southwest Medical University, Luzhou, Sichuan, China. Electronic address:

Article Synopsis
  • Periodontitis is a chronic inflammatory disease that current treatments struggle to effectively manage, prompting research to identify new biomarkers and therapeutic targets using advanced genetic analysis techniques.
  • The study utilized Mendelian randomization and single-cell analysis on large datasets to pinpoint 14 significant drug targets, classifying them into three tiers based on the strength of their association with periodontitis.
  • Results indicated that certain targets showed varying levels of evidence, with some (like TEK and SPP1) posing potential side effects, and further analysis revealed specific enrichment of target genes in immune cells, suggesting their roles in the disease.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!